Teva, GSK Face Another Suit Over Generic Lamictal Deal
Teva Pharmaceutical Industries Ltd. and GlaxoSmithKline LLC were hit Thursday with another proposed class action alleging the companies manipulated a patent settlement to inflate the cost of epilepsy drug Lamictal or...To view the full article, register now.
Already a subscriber? Click here to view full article